Lucía Boix-Palop

ORCID: 0000-0002-4080-0008
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antimicrobial Resistance in Staphylococcus
  • Infective Endocarditis Diagnosis and Management
  • Urinary Tract Infections Management
  • Streptococcal Infections and Treatments
  • Pneumonia and Respiratory Infections
  • COVID-19 Clinical Research Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Liver Disease Diagnosis and Treatment
  • Respiratory viral infections research
  • Enterobacteriaceae and Cronobacter Research
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Genetic Associations and Epidemiology
  • COVID-19 and Mental Health
  • Mycobacterium research and diagnosis
  • Cardiac pacing and defibrillation studies
  • interferon and immune responses
  • Patient Satisfaction in Healthcare
  • Long-Term Effects of COVID-19
  • Nosocomial Infections in ICU
  • Clostridium difficile and Clostridium perfringens research
  • Escherichia coli research studies

Mútua Terrassa
2016-2025

University Hospital Mútua de Terrassa
2020-2025

Universitat Internacional de Catalunya
2016-2024

Universitat de Barcelona
2021-2023

Dartmouth College
2020

Institut d'Investigació Biomédica de Bellvitge
2013

Bellvitge University Hospital
2013

Abstract Objectives To investigate pharmacokinetics (PK) and safety (primary objectives) efficacy (secondary objective) of the investigational monobactam/β-lactamase inhibitor combination aztreonam/avibactam in patients with complicated intra-abdominal infection (cIAI). Methods This Phase 2a open-label, multicentre study (NCT02655419; EudraCT 2015-002726-39) enrolled adults cIAI into sequential cohorts for 5–14 days treatment. Cohort 1 received an loading dose 500/137 mg (30 min infusion),...

10.1093/jac/dkz497 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2019-12-06
Jesús Sojo-Dorado Inmaculada López-Hernández Clara Rosso-Fernández Isabel Morales Zaira R. Palacios‐Baena and 76 more Alicia Hernández‐Torres Esperanza Merino Laura Escolà‐Vergé Elena Bereciartúa Elisa García‐Vázquez Vicente Pintado Lucía Boix-Palop Clara Natera-Kindelán Luisa Sorlí Núria Borrell Livia Giner Concha Amador-Prous Evelyn Shaw A Jover José Molina Rosa Martínez-Álvarez Carlos Dueñas Jorge Calvo Jose T. Silva Miguel Ángel Cárdenes María Lecuona Virginia Pomar Lucía Valiente de Santis Genoveva Yagüe‐Guirao María Ángeles Lobo-Acosta Vicente Merino‐Bohórquez Álvaro Pascual Jesús Rodríguez‐Baño Benito Almirante Mario Fernández José Ramón Paño‐Pardo Marina de Cueto Pilar Retamar Luis Eduardo López-Cortés Belén Gutiérrez‐Gutiérrez Fernando Docobo-Pérez Irene Borreguero Manuel Cameán Encarnación Moral‐Escudero Ana Pareja-Rodríguez de Vera María del Carmen Martínez-Toldos Ana Blázquez-Abellán Alba Bellés Bellés María Fernanda Ramírez-Hidalgo Beatriz Mirelis Esther Calbo Mariona Xercavins Irene Gracia-Ahufinger Angela M. Cano-Yuste Laura Guío Carrión José Luis Hernández-Davó Carlos Pigrau-Serrallach Belen Viñado-Pérez Mireia Puig Asensio Carmen Ardanuy Miquel Pujol Dácil García-Rosado Concepción Gil-Anguita Ana Siverio Adelina Gimeno Vicente Boix-Martínez Sergio Reus Iván Agea-Durán Carmen Fariñas Begoña Palop Helem Vílchez José Antonio Lepe María Victoria Gil-Navarro Rafael San Juan Fernando Cháves Rosa Escudero Francesca Gioia Ana María Sánchez‐Díaz Ana María Cañas-Pedrosa Nayra Sangil-Monroy Carla Toyas-Miazza

<h3>Importance</h3> The consumption of broad-spectrum drugs has increased as a consequence the spread multidrug-resistant (MDR)<i>Escherichia coli</i>. Finding alternatives for these infections is critical, which some neglected may be an option. <h3>Objective</h3> To determine whether fosfomycin noninferior to ceftriaxone or meropenem in targeted treatment bacteremic urinary tract (bUTIs) due MDR<i>E <h3>Design, Setting, and Participants</h3> This multicenter, randomized, pragmatic, open...

10.1001/jamanetworkopen.2021.37277 article EN cc-by-nc-nd JAMA Network Open 2022-01-13

10.1016/s1473-3099(23)00686-2 article EN The Lancet Infectious Diseases 2024-01-09

Infective endocarditis (IE) has high mortality and morbidity requires long hospital stays to deliver the antibiotic treatment recommended in clinical practice guidelines. The objectives were analyze health outcomes of use dalbavancin (DBV) consolidation IEs caused by Gram-positive cocci (GPC) perform a pharmacoeconomic study. This observational, retrospective, Spanish multicenter study patients with IE who received DBV as part phase followed for at least 12 months. was approved Provincial...

10.1016/j.ijantimicag.2023.106918 article EN cc-by-nc-nd International Journal of Antimicrobial Agents 2023-07-11

BackgroundEscherichia coli is the most frequent cause of bloodstream infections (BSIs). About one-third patients with BSIs due to E develop sepsis or shock. The objective this study characterise microbiological features blood isolates causing septic shock provide exploratory information for future diagnostic, preventive, therapeutic interventions.MethodsE from a multicentre cross-sectional older than 14 years presenting (according Third International Consensus Definitions Sepsis and Septic...

10.1016/s2666-5247(23)00369-5 article EN cc-by-nc-nd The Lancet Microbe 2024-03-26

Patients with infective endocarditis (IE) frequently have cardiac implantable electronic devices (CIEDs). Here, we aim to define the clinical profile and prognostic factors of IE in these patients.Infective cases were prospectively identified Spanish National Endocarditis Registry. From 3996 IE, 708 (17.7%) had a CIED 424 CIED-related (lead vegetation). older (68 ± 11 vs. 73 8 years); more comorbidities {pulmonary disease [176 (24.8%) 545 (16.7%)], renal [239 (33.8%) 740 (22.7%)], diabetes...

10.1093/europace/euaa076 article EN EP Europace 2020-03-12

Treatment failure occurs in about 25% of patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. We assessed whether cloxacillin plus fosfomycin achieves better treatment success than alone hospitalized adults MSSA conducted a multicenter, open-label, phase III-IV superiority randomized clinical trial. randomly assigned (1:1) to receive 2 g intravenous every 4 h or 3 6 for the initial 7 days. The primary endpoint was at day 7, composite following criteria: patient...

10.1038/s41591-023-02569-0 article EN cc-by Nature Medicine 2023-10-01
Luis A. Pérez‐Jurado Alejandro Cáceres Laura Balagué-Dobón Tõnu Esko Miguel López de Heredia and 95 more Inés Quintela Raquel Cruz Pablo Lapunzina Ángel Carracedo J. Abellán René Acosta-Isaac José María Aguado Carlos Aguilar Sergio Aguilera Abdolah Ahmadi Sabbagh Jorge Enrique Machado‐Alba Sergiu Albu Karla A. M. Alcalá-Gallardo Julia Alcoba-Flórez Sergio Alcolea Batres Holmes Rafael Algarin-Lara Virginia Almadana Pacheco Kelliane A. Medeiros Júlia Almeida Berta Almoguera María R. Alonso Núria Álvarez Rodolfo Álvarez-Sala Walther Yady Álvarez-Benítez Felipe Álvarez-Navia Katiusse Alves dos Santos Álvaro Andreu-Bernabeu Maria Rosa Antonijoan Eleno Martínez-Aquino Eunate Arana‐Arri C. Monserrat Celso Arango Carolina Araque Nathália Kelly de Araújo Ana Carolina Arcanjo Ana Arnáiz Francisco Arnalich María J. Arranz José Ramón Arribas María-Jesús Artiga Yubelly Avello-Malaver Carmen Ayuso Belén Ballina Martín Raúl C. Baptista‐Rosas Ana María Baldion Andrea Barranco-Díaz María Barreda‐Sánchez Viviana Barrera-Penagos Moncef Belhassen‐García David Bello Enrique Bernal Joao F. Bezerra Marcos Bezerra Natalia Blanca‐López Rafael Blancas Lucía Boix-Palop Alberto M. Borobia Elsa Bravo Marı́a Brión Óscar Brochado-Kith Ramón Brugada Matilde Bustos Alfonso Cabello Juan J. Cáceres-Agra Esther Calbo Enrique J. Calderón Shirley Camacho Francisco C. Ceballos Yolanda Cañadas Cristina Carbonell Servando Cardona‐Huerta María Sánchez-Carpintero Abad Carlos Carpio José Antonio Carrillo-Ávila Marcela C. Campos Carlos Casasnovas Luís Castaño Carlos Castaño Jose E. Castelao Aránzazu Castellano Candalija María A. Castillo Walter G. Chaves-Santiago Sylena Chiquillo-Gómez Marco A. Cid-López Óscar Cienfuegos-Jiménez R. Conde G. Coelho-Palermo Cunha M. Lourdes Cordero-Lorenzana Dolores Corella Almudena Corrales José Luis Cortés-Sánchez Marta Cortón Karla Simone Costa de Souza Fabiola T. C. Silva Luisa Cuesta

Abstract The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed COVID-19 the SCOURGE study, we found 133 cases (1.42%) detectable clonal mosaicism for chromosome alterations (mCA) 226 (5.08%) acquired loss Y (LOY). Individuals mosaic events (mCA and/or LOY) showed a 54% increase risk...

10.1038/s42003-024-05805-6 article EN cc-by Communications Biology 2024-02-19

Background. Infective endocarditis (IE) is a severe condition. Our aim was to describe the profile and prognosis of patients with multivalvular infective (MIE) compare them single-valve IE (SIE). Methods. We used retrospective analysis Spanish Registry (2008−2020). Results. From 4064 definite cases valvular IE, 577 (14.2%) had MIE. In MIE, most common locations were mitral (552, 95.7%) aortic (550, 95.3%), mitral-aortic involvement present in 507 (87.9%). The etiologies S. viridans (192,...

10.3390/jcm11164736 article EN Journal of Clinical Medicine 2022-08-13
José Luis Cabrera-Alarcón Raquel Cruz Marina Rosa-Moreno Ana Latorre Silvia Diz‐de Almeida and 95 more J. Abellán René Acosta-Isaac José María Aguado Carlos Aguilar Sergio Aguilera Abdolah Ahmadi Sabbagh Jorge Enrique Machado‐Alba Sergiu Albu Karla A. M. Alcalá-Gallardo Julia Alcoba-Flórez Sergio Alcolea Batres Holmes Rafael Algarin-Lara Virginia Almadana Pacheco Kelliane A. Medeiros Júlia Almeida Berta Almoguera María R. Alonso Núria Álvarez Rodolfo Álvarez-Sala Walther Yady Álvarez-Benítez Felipe Álvarez-Navia Katiusse Alves dos Santos Álvaro Andreu-Bernabeu Maria Rosa Antonijoan Eleno Martínez-Aquino Eunate Arana‐Arri C. Monserrat Celso Arango Carolina Araque Nathália Kelly de Araújo Ana Carolina Arcanjo Ana Arnáiz Francisco Arnalich María J. Arranz José Ramón Arribas María-Jesús Artiga Yubelly Avello-Malaver Carmen Ayuso Belén Ballina Martín Raúl C. Baptista‐Rosas Ana María Baldion Andrea Barranco-Díaz María Barreda‐Sánchez Viviana Barrera-Penagos Moncef Belhassen‐García David Bello Enrique Bernal Joao F. Bezerra Marcos Bezerra Natalia Blanca‐López Rafael Blancas Lucía Boix-Palop Alberto M. Borobia Elsa Bravo Marı́a Brión Óscar Brochado-Kith Ramón Brugada Matilde Bustos Alfonso Cabello Alejandro Cáceres Juan J. Cáceres-Agra Esther Calbo Enrique J. Calderón Shirley Camacho Francisco C. Ceballos Yolanda Cañadas Cristina Carbonell Servando Cardona‐Huerta María Sánchez-Carpintero Abad Carlos Carpio José Antonio Carrillo-Ávila Marcela C. Campos Carlos Casasnovas Luís Castaño Carlos Castaño Jose E. Castelao Aránzazu Castellano Candalija María A. Castillo Walter G. Chaves-Santiago Sylena Chiquillo-Gómez Marco A. Cid-López Óscar Cienfuegos-Jiménez R. Conde G. Coelho-Palermo Cunha M. Lourdes Cordero-Lorenzana Dolores Corella Almudena Corrales José Luis Cortés-Sánchez Marta Cortón Karla Simone Costa de Souza Fabiola T. C. Silva Raquel Cruz Luisa Cuesta Nathali A. C. Tavares Maria C. C. Carvalho

The frequency of mitochondrial DNA haplogroups (mtDNA-HG) in humans is known to be shaped by migration and repopulation. Mounting evidence indicates that mtDNA-HG are not phenotypically neutral, selection may contribute its distribution. Haplogroup H, the most abundant Europe, improved survival sepsis. Here we developed a random forest trained model for haplogroup calling using data procured from GWAS arrays. Our results reveal context SARS-CoV-2 pandemic, HV branch were found represent...

10.1038/s42003-024-07314-y article EN cc-by-nc-nd Communications Biology 2025-01-09

Background/Objectives: The COVID-19 pandemic resulted in 675 million cases and 6.9 deaths by 2022. Despite substantial declines case fatalities following widespread vaccination campaigns, the threat of future coronavirus outbreaks remains a concern. Current treatments for have been repurposed from existing therapies other infectious non-infectious diseases. Emerging evidence suggests role genetic factors both susceptibility to SARS-CoV-2 infection response treatment. However, comprehensive...

10.3390/biomedicines13030553 article EN cc-by Biomedicines 2025-02-21

Abstract Aim Prolonged antibiotic treatments contribute to increasing antimicrobial resistance. Current guidelines recommend 5–7 days of treatment in patients with surgical infection an adequate source control. Antibiotic stewardship aim optimize the use antibiotics, including their duration. The 7VINCut nationwide intervention aims reduce duration &amp;lt;7 patients. Methods Prospective cohort study conducted 37 hospitals 2019–2022. Patients admitted services &amp;gt;7 were analysed. teams...

10.1093/bjs/znaf024.009 article EN British journal of surgery 2025-02-01
Guillermo Cuervo Marta Hernández‐Meneses Arístides de Alarcón Rafael Luque‐Márquez M. Alonso-Socas and 95 more A. López-Lirola Víctor José González Ramallo Ane Josune Goikoetxea-Agirre David Nicolás Miguel Ángel Goenaga Esperanza Merino Francesc Escrihuela-Vidal Pilar Martín‐Dávila Belén Loeches Lucía Boix-Palop Oriol Gasch Marta Campreciós Alicia Hernández‐Torres Lara García-Álvarez Marcos Pajarón Maria Àngels Ribas Rosa Blanes-Hernández Inmaculada López-Montesinos Luis Eduardo López-Cortés Bárbara Vidal Mariana Fernández-Pittol M.D. Navarro Asunción Moreno Carlos Sala Juan Ambrosioni José M. Miró Rut Andrea Manuel Almela Jorge Alcocer María Ascaso Manuel Azqueta Merçè Brunet Ramón Cartañá Manuel Castellá María Alexandra Cañas Guillermo Cuervo Oriol de Diego Carlos Falces Mateu Espasa Mariana Fernández-Pittol Guillermina Fita David Fuster Cristina García de la Mària Delia García-Pares Marta Hernández‐Meneses Jaume Llopis-Pérez Teresa López‐Cuadrado Francesc Marco José M. Miró Asunción Moreno David Nicolás Salvador Pié i Ninot Marta Rodrı́guez-Créixems Carlos Paré Daniel Pereda Juan M. Pericàs Andrés Perissinotti José L. Pomar Eduard Quintana José Ramírez Ander Regueiro Carlos Gómez Roca Mercè Roque Irene Rovira Elena Sandoval Laura Sanchís Marta Sitges Dolors Soy Adrián Téllez José Marı́a Tolosana Xabier Urra Bárbara Vidal Montse Tuset Jordi Vilà Arístides de Alarcón Dolores Navarro-Amuedo Encarnación Gutiérrez‐Carretero José Antonio Lepe José López‐Haldón Rafael Luque‐Márquez Guillermo Marín Antonio Ortiz-Carrellán Eladio Sánchez-Domínguez Manuel Poyato Borrego M.M. Alonso Beatriz Castro Teresa Delgado-Melian Javier Fernández-Sarabia Dácil García-Rosado Julia González González Juan Lacalzada‐Almeida Lissete Lorenzo de la Peña Alina Pérez-Ramírez Pablo César Prada-Arrondo F. Rodríguez-Moreno

The POET trial demonstrated that moving from intravenous to oral antibiotics in stable patients with left-sided infective endocarditis (IE) was noninferior fully parenteral treatment. However, it did not compare outpatient strategies. OraPAT-IE GAMES is a noninferiority, multicenter, randomized, open-label study aimed partial versus antibiotic therapy (OPAT) for consolidation of treatment IE. A total 342 IE caused by selected micro-organisms will eventually be included. After minimum 10 days...

10.1007/s40121-025-01110-9 article EN cc-by-nc Infectious Diseases and Therapy 2025-03-01

Abstract Background/Objectives To assess the microbiological and clinical features of Klebsiella pneumoniae healthcare-associated bacteraemia urinary origin (HCA-BUO) in Spain, with a particular focus on third generation cephalosporin-(3GCR-Kp) carbapenem-resistant (CR-Kp) isolates. Methods A total 96 (21.4%, 96/449) K. blood isolates were prospectively collected from patients HCA-BUO (n=443) 12 tertiary-care hospitals Spain (2017-2019). Antimicrobial susceptibility was determined (standard...

10.1093/ofid/ofaf164 article EN cc-by-nc-nd Open Forum Infectious Diseases 2025-03-12

We investigated the effectiveness of early oral switch for treating Enterobacterales bloodstream infection (BSI) by performing a post hoc emulation trial SIMPLIFY trial. conducted analysis randomised controlled specified target characteristics selecting patients who achieved clinical stability on day 5. categorised into those switched 5 and continued intravenously. The primary outcome was cure at test cure. set propensity score being to reduce confounding. ran simple,...

10.1016/j.ijid.2025.107917 article EN cc-by-nc-nd International Journal of Infectious Diseases 2025-04-01

Cerebrovascular complications are frequent in pneumococcal meningitis and associated with poor functional outcomes. Among these complications, the incidence of cerebral vasculitis (CV) has been increasingly reported, but neither its pathogenesis nor relationship cortisone treatment have conclusively established. We wanted to describe cerebrospinal fluid (CSF) metalloprotease (MMP) levels, which linked damage (MMP-2, MMP-9, antagonist TIMP-1), differences microbiological serotypes or...

10.1038/s41598-025-99883-z article EN cc-by-nc-nd Scientific Reports 2025-05-06

Abstract Background Catheter-related bloodstream infections (CRBSIs) increase morbidity and mortality, prolong hospitalization generate considerable medical costs. Recent guidelines for CRBSI recommend empirical therapy against Gram-positive bacteria (GPB) restrict coverage Gram-negative (GNB) only to specific circumstances. Objectives To investigate predictors of GNB aetiology in assess the outcome patients with CRBSI. Methods Patients were selected from PROBAC cohort, a prospective,...

10.1093/jac/dkaa262 article EN Journal of Antimicrobial Chemotherapy 2020-07-08

Guidelines recommend 5-7 days of antibiotic treatment in patients with surgical infection and adequate source control. This nationwide stewardship intervention aimed to reduce the duration treatments <7 days.Prospective cohort study evaluating receiving antibiotics ≥7 32 hospitals. Indication for treatment, quality control, type recommendations issued, adherence were analysed. Temporal trends percentages >7 evaluated using a linear regression model Pearson's correlation coefficients.A total...

10.1016/j.ijantimicag.2023.106943 article EN cc-by-nc-nd International Journal of Antimicrobial Agents 2023-08-02
Coming Soon ...